Smoking: Pathogenetic Mechanisms, Possibilities of Medical Correction (Literature Review)
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The smoking epidemic is one of the greatest threats to human health, as it is the leading cause of death worldwide, as well as many preventable diseases. Diseases associated with smoking include cardiovascular disease, atherosclerosis, type 2 diabetes, chronic pancreatitis, chronic obstructive pulmonary disease, cancer, osteoporosis and others.
The aim is to analyze information on the pathogenetic mechanisms of tobacco exposure and methods of its drug correction.
Among the 4,000 chemicals identified in tobacco smoke, nicotine is the main active ingredient in tobacco products. It is highly toxic and potentially lethal.
Nicotine affects many systems, including the neurological, neuromuscular, cardiovascular, respiratory, immunological and gastrointestinal systems. Therefore, nicotine-containing drugs reduce the symptoms of nicotine withdrawal in regular smokers who abstain from smoking. The presence of different types of nicotinic acetylcholine receptors, their regulation and desensitization affect these complex physiological effects.
Nicotine replacement drugs contain pure nicotine, in order to reduce the patient’s propensity to use tobacco, physiological and psychomotor withdrawal symptoms. They increase the level of nicotine in the blood, thus facilitating the transition from cigarette smoking to complete abstinence. Smokers can quit without using nicotine-containing drugs, but most those who try do not succeed on the first try. Nicotine replacement drugs only affect physical dependence.
Nicotine is the main factor responsible for dependence on cigarette smoking, and its rate of absorption and entry into the brain are considered key factors responsible for the high potential for abuse of this drug. The advantage of nicotine-containing drugs is the patient’s independence from the method of administration, determination of abstinence, duration of treatment, level of supportive counseling, place of treatment (hospital, clinic or support group), as well as fixed, variable or reduced doses. There are a number of nicotine-containing drugs in various forms that effectively promote smoking cessation in adults.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Aquilina, N.J., Havel, C.M., Cheung, P., Harrison, R.M., Ho, K.F., Benowitz, N.L., & Jacob III, P. Ubiquitous atmospheric contamination by tobacco smoke: Nicotine and a new marker for tobacco smoke-derived particulate matter, nicotelline. Environment International. 2021;150:106417.
Aslam, M., Jagtap, N., Karyampudi, A., Talukdar, R., & Reddy, D. N. Risk factors for development of endocrine insufficiency in chronic pancreatitis. Pancreatology. 2021;21(1):15-20.
Berridge, V., Hall, W., Taylor, S., Gartner, C., & Morphett, K. A first pass, using pre-history and contemporary history, at understanding why Australia and England have such different policies towards electronic nicotine delivery systems. 2021. 1970s-c. 2018. Addiction.
Bird, D., & Ravindra, N.M. Transdermal drug delivery and patches – an overview. Medical Devices & Sensors. 2020;3(6):e10069.
Budakoti, A., Choudhary, A., Sultana, F., Kaushal, P., Naryal, R., & Burgus, M.G. Evaluation Of Prevalence And Incidence Of Smokeless And Smoking Form Of Tobacco With Correlation With Fagerstrom Nicotine Dependence Test And NRT Therapy – A Cross-Sectional Survey. European Journal of Molecular & Clinical Medicine. 2021;7(7):6904-15.
Cunningham, J.A., Leatherdale, S.T., Chaiton, M., Tyndale, R., Schell, C., & Godinho, A. Offering nicotine patches to all households in a community with high smoking rates: Pilot test of a population-based approach to promote tobacco cessation. International Journal of Population Data Science. 2021;6(1).
Devi, R.E., Barman, D., Sinha, S., Hazarika, S.J., & Das, S. Nicotine replacement therapy: A friend or foe. Journal of Family Medicine and Primary Care. 2020;9(6):2615.
Dusautoir, R., Zarcone, G., Verriele, M., Garçon, G., Fronval, I., Beauval, N., ... & Anthsrieu, S. Comparison of the chemical composition of aerosols from heated tobacco products, electronic cigarettes and tobacco cigarettes and their toxic impacts on the human bronchial epithelial BEAS-2B cells. Journal of Hazardous Materials. 2021;401:123417.
Emgenbroich, M., Wauer, G., Linn, M., Böhm, R., Schmitz, C., Kaufmann, R., ... & Schlüter, A. US patent application. 2021;16:979, 575.
Graves, B.M., Johnson, T.J., Nishida, R.T., Dias, R.P., Savareear, B., Harynuk, J.J., ... & Boies, A. M. Comprehensive characterization of mainstream marijuana and tobacco smoke. Scientific reports. 2020;10(1):1-12.
Gubner, N.R., & Benowitz, N.L. Neurobiology of Nicotine and Tobacco. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment, 2021, 265.
Hansson A, Rasmussen T, Perfekt R, Hall E, Kraiczi H. Effect of nicotine 6 mg gum on urges to smoke, a randomized clinical trial. BMC Pharmacol Toxicol. 2019 Nov 21;20(1):69. DOI: 10.1186/s40360-019-0368-9.
Haokip, H.R., Kumar, R., Rawat, V.S., & Sharma, S.K. Efficacy of standard nicotine replacement therapy (NRT) versus video-assisted nurse-led NRT on tobacco cessation: A randomized controlled pilot trial. Clinical Epidemiology and Global Health, 2021;9:141-6.
Hashimoto, H., Maruhashi, T., Yamaji, T., Harada, T., Han, Y., Takaeko, Y., ... & Higashi, Y. Smoking status and endothelial function in Japanese men. Scientific Reports. 2021;11(1):1-8.
Jafari, A., Rajabi, A., Gholian-Aval, M., Peyman, N., Mahdizadeh, M., & Tehrani, H. National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis. Environmental Health and Preventive Medicine. 2021;26(1):1-13.
Kamala, K. A., Sankethguddad, S., & Sujith, S.G. An update on nicotine replacement therapy. Journal of Oral Research and Review. 2019;11(1):41.
Karadag, B., Dağli, E., & Yildiz, F. Preventing tobacco use and exposure to second-hand tobacco smoke in pregnancy. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society. 2021. 273-86 р.
Lei, L., & Liu, F. Medicaid coverage and use of nicotine replacement treatment. Economics & Human Biology. 2021;40:100938.
Levin, M.G., Klarin, D., Assimes, T.L., Freiberg, M.S., Ingelsson, E., Lynch, J., ... & Damrauer, S.M. Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study. JAMA network open. 2021;4(1):e2034461-e2034461.
Liakoni, E., & Benowitz, N.L. Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society. 2021. 97-117 р.
Liu, J., Wang, J., Vansickel, A., Edmiston, J., Graff, D., & Sarkar, M. Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum. Clinical Pharmacology in Drug Development, 2021.
Lyall, V., Guy, J., Egert, S., Pokino, L.A., Rogers, L., & Askew, D. «They Were Willing to Work with Me and Not Pressure Me»: A Qualitative Investigation into the Features of Value of a Smoking Cessation in Pregnancy Program for Aboriginal and Torres Strait Islander Women. International Journal of Environmental Research and Public Health. 2021;18(1):49.
Mathis, C., Smart, D.J., Xia, W., Phillips, B.W., Peitsch, M.C., Szostak, J., ... & Luettich, K. Residual Risk of Nicotine. In Toxicological Evaluation of Electronic Nicotine Delivery Products, 2021. 513-87 р. Academic Press.
Nourse Jr, J.B., Harshefi, G., Marom, A., Karmi, A., Ben-Ami, H.C., Caldwell, K.A., ... & Treinin, M. Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress. iScience, 2021.102140.
Palmer, R.H., Benca-Bachman, C.E., Huggett, S.B., Bubier, J.A., Mc-Geary, J.E., Ramgiri, N., ... & Chesler, E.J. Multi-omic and multi-species meta-analyses of nicotine consumption. Translational Psychiatry. 2021;11(1):1-10.
Panda, A., Sharma, P.K., Shivakumar, H.N., Repka, M.A., & Murthy, S. N. Nicotine loaded dissolving microneedles for nicotine replacement therapy. Journal of Drug Delivery Science and Technology. 2021;61:102300.
Park, S., Han, K., Lee, S., Kim, Y., Lee, Y., Kang, M.W., ... & Kim, D.K. Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people. Plos one. 2021;16(1):e0241623.
Pogun, S., & Arman, A.R. Understanding nicotine addiction and the health effects of nicotine use. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021. 18-32 р.
Shaik, F.B., Nagajothi, G., Swarnalatha, K., Kumar, C.S., Rajendra, W., & Maddu, N. Correlation between smokeless tobacco (Gutkha) and biomarkers of oxidative stress in plasma with cardiovascular effects. Heliyon. 2021;7(2):e05487.
Smaily, H., Khalaf, M., Melkane, A. E., Helou, D., Richa, T., Khoury, C., ... & Matar, N. Smoking cessation intervention for patients with head and neck cancer: a prospective randomized controlled trial. American Journal of Otolaryngology. 2021;42(1):102832.
Snell, M., Harless, D., Shin, S., Cunningham, P., & Barnes, A. A longitudinal assessment of nicotine dependence, mental health, and attempts to quit Smoking: Evidence from waves 1–4 of the Population Assessment of Tobacco and Health (PATH) study. Addictive Behaviors. 2021;115:106787.
Thomas, R., Parker, L.S., & Shiffman, S. The ethics of tobacco harm reduction: An analysis of e-cigarette availability from the perspectives of utilitarianism, bioethics, and public health ethics. Nicotine and Tobacco Research. 2021;23(1):3-8.
Williams, J.M., & Chaguturu, V. Treatment of Tobacco-Related Disorders. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment, 2021. 279 р.
World Health Organization. WHO report on the global tobacco epidemic, 2011: warning about the dangers of tobacco. Geneva: World Health Organization, 2011.
Samotieikina, А.А., & Popova, Т.М. Influence of smoking type on vascular endothelium (Doctoral dissertation) (2021).
